NCT05739565

Brief Summary

Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active. Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence. Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care. Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity. However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity. This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients:

  • 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers)
  • 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up
  • 3-Support by health professionals (attending physician) through the prescription of physical activity. The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
850

participants targeted

Target at P75+ for not_applicable prostate-cancer

Timeline
29mo left

Started Apr 2023

Typical duration for not_applicable prostate-cancer

Geographic Reach
1 country

25 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Apr 2023Sep 2028

First Submitted

Initial submission to the registry

January 26, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 22, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 25, 2023

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

4.4 years

First QC Date

January 26, 2023

Last Update Submit

November 21, 2025

Conditions

Keywords

Physical activityprostate cancerinterventional research

Outcome Measures

Primary Outcomes (1)

  • Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures the intensity of physical activity)

    via actimetry (Actigraph GT9x, Pensacola, Florida, USA) 12 months (+/- 1 month) after the patient's inclusion in the Acti-Pair program

    Month: 12

Secondary Outcomes (19)

  • Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures intensity of physical activity)

    Inclusion, 3, 6 and 12 months

  • Objective measure of physical inactivity (in h/d)

    Inclusion, 3, 6 and 12 months

  • Subjective measurement of physical activity (in Metabolic equivalent of task-h/week) and sedentary time (h/d)

    Inclusion, 3, 6 and 12 months

  • Measurement of physical capacity: walking distance (meters)

    Inclusion, 3, 6 and 12 months

  • Measurement of muscle strength: biceps muscle strength (kg)

    Inclusion, 3, 6 and 12 months

  • +14 more secondary outcomes

Study Arms (2)

Acti-Pair program

EXPERIMENTAL

* Motivational support by the peer (a patient with the same pathology who meets the WHO recommendations for physical activity), who will provide motivational follow-up * The implementation of a personalized and realistic physical activity project for the patient via the physical activity support systems (sport health centers) * Support from health professionals (GP) via the prescription of physical activity and from adapted physical activity (APA) professionals

Behavioral: Acti-Pair program

Usual care

NO INTERVENTION

The control group will be made up of patients followed up for prostate cancer and benefiting from usual care which consists of giving advice and recommendations for physical activity in consultation, aiming to make patients more active in their daily lives (=usual practice, physical activity to be carried out independently, at home).

Interventions

Motivational support by the peer (a patient with the same pathology who meets the WHO recommendations for physical activity), who will provide motivational follow-up * The implementation of a personalized and realistic physical activity project for the patient via the physical activity support systems (sport health centers) * Support from health professionals (GP) via the prescription of physical activity and from adapted physical activity (APA) professionals

Acti-Pair program

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients:
  • Age ≥ 18 years
  • Diagnosed with prostate cancer for at least 1 year
  • PA practice \< 150 minutes per week (considered inactive according to WHO)
  • Affiliated or entitled to a social security scheme
  • Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study

You may not qualify if:

  • For patients:
  • Undergoing treatment (except hormone therapy)
  • Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies
  • Deprived of liberty or under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (25)

Activité Physique Adaptée - CDOS Savoie

Chambéry, France

NOT YET RECRUITING

CH Chambéry

Chambéry, France

NOT YET RECRUITING

Activité Physique Adaptée - DAHLIR 63

Clermont-Ferrand, France

NOT YET RECRUITING

CHU Clermont-Ferrand - ONCOLOGIE

Clermont-Ferrand, France

NOT YET RECRUITING

CHU Clermont-Ferrand - Urologie

Clermont-Ferrand, France

NOT YET RECRUITING

Activité Physique Adaptée - CDOS Isère

Grenoble, France

NOT YET RECRUITING

CHU Grenoble - Urologie

Grenoble, France

NOT YET RECRUITING

Activité Physique Adaptée - DAHLIR 43

Le Puy-en-Velay, France

NOT YET RECRUITING

CH Le Puy en Velay

Le Puy-en-Velay, France

NOT YET RECRUITING

HCL - Hôpital Edouard Herriot

Lyon, 69000, France

NOT YET RECRUITING

HCL - Hôpital Croix Rousse

Lyon, 69004, France

NOT YET RECRUITING

Activité Physique Adaptée - DAHLIR 69

Lyon, France

NOT YET RECRUITING

CLB - Oncologie

Lyon, France

NOT YET RECRUITING

CLB - Radiothérapie

Lyon, France

NOT YET RECRUITING

HCL - CH Lyon Sud

Lyon, France

NOT YET RECRUITING

Activité Physique Adaptée - CDOS Ardèche

Privas, France

NOT YET RECRUITING

CH Roanne

Roanne, France

NOT YET RECRUITING

Activité Physique Adaptée - DAPAP 42

Saint-Etienne, France

NOT YET RECRUITING

CHU Saint-Etienne - Oncologie

Saint-Etienne, France

RECRUITING

CHU Saint-Etienne - Radiothérapie

Saint-Etienne, France

NOT YET RECRUITING

Hôpital Privé de la Loire

Saint-Etienne, France

RECRUITING

Clinique du parc

Saint-Priest-en-Jarez, 42270, France

NOT YET RECRUITING

Activité Physique Adaptée - CDOS Drôme

Valence, France

NOT YET RECRUITING

Hôpitaux Drôme Nord - Valence

Valence, France

NOT YET RECRUITING

Radiologie Drôme-Ardèche - Valence

Valence, France

NOT YET RECRUITING

Related Publications (12)

  • Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, Gronberg H, Balter K. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):57-64. doi: 10.1158/1055-9965.EPI-14-0707. Epub 2014 Dec 19.

    PMID: 25527697BACKGROUND
  • Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 1;71(11):3889-95. doi: 10.1158/0008-5472.CAN-10-3932. Epub 2011 May 24.

    PMID: 21610110BACKGROUND
  • Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA. Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study. J Cancer Surviv. 2015 Sep;9(3):500-11. doi: 10.1007/s11764-015-0426-2. Epub 2015 Apr 16.

    PMID: 25876555BACKGROUND
  • Steindorf K, Depenbusch J, Haussmann A, Tsiouris A, Schmidt L, Hermann S, Sieverding M, Wiskemann J, Ungar N. Change patterns and determinants of physical activity differ between breast, prostate, and colorectal cancer patients. Support Care Cancer. 2020 Jul;28(7):3207-3218. doi: 10.1007/s00520-019-05097-1. Epub 2019 Nov 13.

    PMID: 31720802BACKGROUND
  • Blaney JM, Lowe-Strong A, Rankin-Watt J, Campbell A, Gracey JH. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology. 2013 Jan;22(1):186-94. doi: 10.1002/pon.2072. Epub 2011 Oct 6.

    PMID: 23296635BACKGROUND
  • Livingston PM, Craike MJ, Salmon J, Courneya KS, Gaskin CJ, Fraser SF, Mohebbi M, Broadbent S, Botti M, Kent B; ENGAGE Uro-Oncology Clinicians' Group. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE). Cancer. 2015 Aug 1;121(15):2646-54. doi: 10.1002/cncr.29385. Epub 2015 Apr 15.

    PMID: 25877784BACKGROUND
  • Tudor-Locke C, Lauzon N, Myers AM, Bell RC, Chan CB, McCargar L, Speechley M, Rodger NW. Effectiveness of the First step Program delivered by professionals versus peers. J Phys Act Health. 2009 Jul;6(4):456-62. doi: 10.1123/jpah.6.4.456.

    PMID: 19842459BACKGROUND
  • Buman MP, Giacobbi PR Jr, Dzierzewski JM, Morgan AA, McCrae CS, Roberts BL, Marsiske M. Peer Volunteers Improve Long-Term Maintenance of Physical Activity With Older Adults: A Randomized Controlled Trial. J Phys Act Health. 2011 Sep;8(s2):S257-S266. doi: 10.1123/jpah.8.s2.s257.

    PMID: 28829716BACKGROUND
  • Pinto BM, Stein K, Dunsiger S. Peers promoting physical activity among breast cancer survivors: A randomized controlled trial. Health Psychol. 2015 May;34(5):463-72. doi: 10.1037/hea0000120. Epub 2014 Aug 11.

    PMID: 25110844BACKGROUND
  • Galvao DA, Newton RU, Girgis A, Lepore SJ, Stiller A, Mihalopoulos C, Gardiner RA, Taaffe DR, Occhipinti S, Chambers SK. Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation. Psychooncology. 2018 Jan;27(1):199-207. doi: 10.1002/pon.4495. Epub 2017 Jul 27.

    PMID: 28685892BACKGROUND
  • Baudot A, Barth N, Colas C, Garros M, Garcin A, Oriol M, Roche F, Chauvin F, Mottet N, Hupin D; on behalf the Acti-Pair investigators. The physical activity experience of prostate cancer patients: a multicentre peer motivation monitoring feasibility study. The Acti-Pair study. Pilot Feasibility Stud. 2022 Jan 21;8(1):12. doi: 10.1186/s40814-022-00966-9.

    PMID: 35063040BACKGROUND
  • Baudot A, Fayolle E, Garros M, Barth N, Colin F, Presles E, Oriol M, Collange F, Chauvin F, Bourmaud A, Hupin D. Impact of the Acti-Pair programme on physical activity in patients with prostate cancer: protocol of the Acti-Pair 2 stepped-wedge cluster randomised trial. BMJ Open Sport Exerc Med. 2024 Dec 22;10(4):e002344. doi: 10.1136/bmjsem-2024-002344. eCollection 2024.

MeSH Terms

Conditions

Prostatic NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehavior

Study Officials

  • David HUPIN, MD PhD

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2023

First Posted

February 22, 2023

Study Start

April 25, 2023

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2028

Last Updated

November 24, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations